Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specific Survey of Norditropin® in Achondroplasia: Survey for Long-term Application

NCT01516229 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01516229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01516229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specific Survey of Norditropin® in Achondroplasia: Survey for Long-term Application
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
May 1, 1997
Completion date
March 31, 2007
Enrollment
395 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

achondroplasia, genetic disorder